Cargando…
Retracted: Efficacy and Safety of PD-1/PD-L1 Inhibitor Chemotherapy Combined with Lung Cancer Fang No. 1 in Relapsed and Refractory SCLC: A Retrospective Observational Study
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Hindawi
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10322414/ https://www.ncbi.nlm.nih.gov/pubmed/37416284 http://dx.doi.org/10.1155/2023/9870685 |
| _version_ | 1785068749523517440 |
|---|---|
| author | Methods in Medicine, Computational and Mathematical |
| author_facet | Methods in Medicine, Computational and Mathematical |
| author_sort | Methods in Medicine, Computational and Mathematical |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10322414 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Hindawi |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-103224142023-07-06 Retracted: Efficacy and Safety of PD-1/PD-L1 Inhibitor Chemotherapy Combined with Lung Cancer Fang No. 1 in Relapsed and Refractory SCLC: A Retrospective Observational Study Methods in Medicine, Computational and Mathematical Comput Math Methods Med Retraction Hindawi 2023-06-28 /pmc/articles/PMC10322414/ /pubmed/37416284 http://dx.doi.org/10.1155/2023/9870685 Text en Copyright © 2023 Computational and Mathematical Methods in Medicine. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Retraction Methods in Medicine, Computational and Mathematical Retracted: Efficacy and Safety of PD-1/PD-L1 Inhibitor Chemotherapy Combined with Lung Cancer Fang No. 1 in Relapsed and Refractory SCLC: A Retrospective Observational Study |
| title | Retracted: Efficacy and Safety of PD-1/PD-L1 Inhibitor Chemotherapy Combined with Lung Cancer Fang No. 1 in Relapsed and Refractory SCLC: A Retrospective Observational Study |
| title_full | Retracted: Efficacy and Safety of PD-1/PD-L1 Inhibitor Chemotherapy Combined with Lung Cancer Fang No. 1 in Relapsed and Refractory SCLC: A Retrospective Observational Study |
| title_fullStr | Retracted: Efficacy and Safety of PD-1/PD-L1 Inhibitor Chemotherapy Combined with Lung Cancer Fang No. 1 in Relapsed and Refractory SCLC: A Retrospective Observational Study |
| title_full_unstemmed | Retracted: Efficacy and Safety of PD-1/PD-L1 Inhibitor Chemotherapy Combined with Lung Cancer Fang No. 1 in Relapsed and Refractory SCLC: A Retrospective Observational Study |
| title_short | Retracted: Efficacy and Safety of PD-1/PD-L1 Inhibitor Chemotherapy Combined with Lung Cancer Fang No. 1 in Relapsed and Refractory SCLC: A Retrospective Observational Study |
| title_sort | retracted: efficacy and safety of pd-1/pd-l1 inhibitor chemotherapy combined with lung cancer fang no. 1 in relapsed and refractory sclc: a retrospective observational study |
| topic | Retraction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10322414/ https://www.ncbi.nlm.nih.gov/pubmed/37416284 http://dx.doi.org/10.1155/2023/9870685 |
| work_keys_str_mv | AT methodsinmedicinecomputationalandmathematical retractedefficacyandsafetyofpd1pdl1inhibitorchemotherapycombinedwithlungcancerfangno1inrelapsedandrefractorysclcaretrospectiveobservationalstudy |